Drugs / Split, Inactivated, Trivalent Influenza Vaccine
Split, Inactivated, Trivalent Influenza Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00391391 | Oct 2006 → Mar 2007 | influenza | Sanofi | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00388583 Comparator | Sep 2006 → Jun 2007 | influenza | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Split, Inactivated, Trivalent Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00388583 ↗ |
| Modality | Vaccine | “Inactivated, Split-Virion Influenza Vaccine” NCT00388583 ↗ |